Acute expression of RET/PTC induces isozyme-specific activation and subsequent downregulation of PKCε in PCCL3 thyroid cells

Oncogene

Volumn 22, Issue 44, 2003, Pages 6830-6838

  Knauf, Jeffrey A ^a   Ouyang, Bin ^a   Croyle, Mickey ^a   Kimura, Edna ^a   Fagin, James A ^a  

^a UNIVERSITY OF CINCINNATI COLLEGE OF MEDICINE   (United States)

Author keywords

Apoptosis; Phospholipase C ; Protein kinase C; RET PTC; Thyroid

Indexed keywords

DOXORUBICIN; PHOSPHOLIPASE C; PROTEIN KINASE C EPSILON; PROTEIN RET;

ANIMAL CELL; APOPTOSIS; ARTICLE; CELL SURVIVAL; CLONOGENESIS; ENZYME ACTIVATION; GENE REARRANGEMENT; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; THYROID CELL; THYROID PAPILLARY CARCINOMA;

ANIMALS; APOPTOSIS; CARCINOMA, PAPILLARY; CELL SURVIVAL; DOWN-REGULATION; DOXORUBICIN; ENZYME ACTIVATION; GENE EXPRESSION REGULATION, NEOPLASTIC; ISOENZYMES; PROTEIN KINASE C; PROTO-ONCOGENE PROTEINS; PROTO-ONCOGENE PROTEINS C-RET; RATS; RECEPTOR PROTEIN-TYROSINE KINASES; THYROID NEOPLASMS; TUMOR CELLS, CULTURED;

ANIMALIA;

EID: 0242406737     PISSN: 09509232     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.onc.1206829     Document Type: Article

References (44)

1. Ahmad S, Mineta T, Martuza RL and Glazer RI. (1994). Neurosurgery, 35, 904-908.
2. Blobe GC, Obeid LM and Hannun YA. (1994). Cancer Metastasis Rev., 13, 411-431.
3. Borrello MG, Smith DP, Pasini B, Bongarzone I, Greco A, Lorenzo MJ, Arighi E, Miranda C, Eng C and Alberti L. (1995). Oncogene, 11, 2419-2427.
4. Cacace AM, Guadagno SN, Krauss RS, Fabbro D and Weinstein IB. (1993). Oncogene, 8, 2095-2104.
5. Castellone MD, Cirafici AM, De Vita G, De Falco V, Malorni L, Tallini G, Fagin JA, Fusco A, Melillo RM and Santoro M. (2003). Oncogene, 22, 246-255.
6. Dempsey EC, Newton AC, Mochly-Rosen D, Fields AP, Reyland ME, Insel PA and Messing RO. (2000). Am. J. Physiol. Lung Cell Mol. Physiol., 279, L429-L438.
7. DiGiovanni J. (1992). Pharmacol. Ther., 54, 63-128.
8. Downward J. (1998). Curr. Opin. Genet. Dev., 8, 49-54.
9. Durick K, Wu RY, Gill GN and Taylor SS. (1996). J. Biol. Chem., 271, 12691-12694.
10. Fagin JA. (2002). Endocrinology, 143, 2025-2028.
11. Fujimoto J and Brenner-Gati L. (1992). Endocrinology, 130, 1587-1592.
12. Fusco A, Berlingieri MT, Di Fiore PP, Portella G, Grieco M and Vecchio G. (1987). Mol. Cell Biol., 7, 3365-3370.
13. Gamard CJ, Blobe GC, Hannun YA and Obeid LM. (1994). Cell Growth Differ., 5, 405-409.
14. Gossen M and Bujard H. (1992). Proc. Natl. Acad. Sci. USA, 89, 5547-5551.
15. Gossen M and Bujard H. (1993). Nucleic. Acids. Res., 21, 4411-4412.
16. Gossen M, Freundlieb S, Bender G, Muller G, Hillen W and Bujard H. (1995). Science, 268, 1776-1769.
17. Hug H and Sarre TF. (1993). Biochem. J., 291, 329-343.
18. Kim MJ, Kim E, Ryu SH and Suh PG. (2000). Exp. Mol. Med., 32, 101-109.
19. Knauf JA, Elisei R, Mochly-Rosen D, Liron T, Chen XN, Gonsky R, Korenberg JR and Fagin JA. (1999). J. Biol. Chem., 274, 23414-23425.
20. Knauf JA, Ward LS, Nikiforov YE, Nikiforova M, Puxeddu E, Medvedovic M, Liron T, Mochly-Rosen D and Fagin JA. (2002). J. Clin. Endocrinol. Metab., 87, 2150-2159.
21. Lu Z, Liu D, Hornia A, Devonish W, Pagano M and Foster DA. (1998). Mol. Cell. Biol., 18, 839-845.
22. Maddens S, Charruyer A, Plo I, Dubreuil P, Berger S, Salles B, Laurent G and Jaffrezou JP. (2002). Blood, 100, 1294-1301.
23. Marks F and Gschwendt M. (1995). Mutat. Res., 333, 161-172.
24. Mikaelian I and Sergeant A. (1992). Nucleic Acids Res., 20, 376.
25. Mischak H, Goodnight JA, Kolch W, Martiny-Baron G, Schaechtle C, Kazanietz MG, Blumberg PM, Pierce JH and Mushinski JF. (1993). J. Biol. Chem., 268, 6090-6096.
26. Mochly-Rosen D and Gordon AS. (1998). FASEB J., 12, 35-42.
27. Muller PY, Janovjak H, Miserez AR and Dobbie Z. (2002). Biotechniques, 32, 1372-1379.
28. Murray NR and Fields AP. (1998). J. Biol. Chem., 273, 11514-11520.
29. Neri LM, Bortul R, Borgatti P, Tabellini G, Baldini G, Capitani S and Martelli AM. (2002). Mol. Biol. Cell, 13, 947-964.
30. O'Brian CA and Ward NE. (1989). Cancer Metastasis Rev., 8, 199-214.
31. Ohmori T and Arteaga CL. (1998). Cell Growth Differ., 9, 345-353.
32. Plo I, Lautier D, Casteran N, Dubreuil P, Arock M and Laurent G. (2001). Oncogene, 20, 6752-6763.
33. Ron D and Kazanietz MG. (1999). FASEB J., 13, 1658-1676.
34. Saavedra HI, Knauf JA, Shirokawa JM, Wang J, Ouyang B, Elisei R, Stambrook PJ and Fagin JA. (2000). Oncogene, 19, 3948-3954.
35. Santoro M, Melillo RM, Carlomagno F, Fusco A and Vecchio G. (2002). Ann. N. Y. Acad. Sci., 963, 116-121.
36. Sawai H, Okazaki T, Takeda Y, Tashima M, Sawada H, Okuma M, Kishi S, Umehara H and Domae N. (1997). J. Biol. Chem., 272, 2452-2458.
37. Schechtman D and Mochly-Rosen D. (2001). Oncogene, 20, 6339-6347.
38. Shinomura T, Asaoka Y, Oka M, Yoshida K and Nishizuka Y. (1991). Proc. Natl. Acad. Sci. USA, 88, 5149-5153.
39. Shirokawa JM, Elisei R, Knauf JA, Hara T, Wang J, Saavedra HI and Fagin JA. (2000). Mol. Endocrinol., 14, 1725-1738.
40. Vecchio G and Santoro M. (2000). Clin. Chem. Lab. Med., 38, 113-116.
41. Viglietto G, Chiappetta G, Martinez-Tello FJ, Fukunaga FH, Tallini G, Rigopoulou D, Visconti R, Mastro A, Santoro M and Fusco A. (1995). Oncogene, 11, 1207-1210.
42. Wang J, Knauf JA, Basu S, Puxeddu E, Kuroda H, Santoro M, Fusco A and Fagin JA. (2003). Mol. Endocrinol., 17, 1425-1436.
43. Wooten MW, Zhou G, Seibenhener ML and Coleman ES. (1994). Cell Growth Differ., 5, 395-403.
44. Zhuang S, Hirai S, Mizuno K, Suzuki A, Akimoto K, Izumi Y, Yamashita A and Ohno S. (1997). Biochem. Biophys. Res. Commun., 240, 273-278.